Nexien BioPharma, Inc (OTC: NXEN) Developing a cannabinoid-based drug pipeline.

November 14, 2018 admin CEO Interview, Healthcare Comments Off on Nexien BioPharma, Inc (OTC: NXEN) Developing a cannabinoid-based drug pipeline.
Alex Wasyl, CEO Nexien BioPharma

 

 

 

Alex Wasyl, CEO Nexien BioPharma

 

 

 

 

 

 

Nexien BioPharma, Inc (OTC: NXEN) CEO Interview with Alex Wasyl discussing the company’s cannabinoid-based drug development pipeline. Drug development targets include, epliepsy, myotonia and other markets.

Get our FREE Newsletter! Discover Stocks with +1,000% Upside Potential!
Join over 100,000 investors and business leaders worldwide. Discover the Next Super Stock before the rest of the crowd.
Your privacy is our priority. Your email address will never be sold or shared with anyone else.




Related Articles

Healthcare

NEXT SUPER STOCK: CytoDyn, Inc. (OTC: CYDY) January 23, 2020 Conference Presentation

January 23, 2020 admin Healthcare, Investor Presentations Comments Off on NEXT SUPER STOCK: CytoDyn, Inc. (OTC: CYDY) January 23, 2020 Conference Presentation

CytoDyn, Inc. (OTC: CYDY) Next Super Stock investor conference presentation January 23, 2020 CEO Dr. Nader Pourhassan, Ph.D, discusses CytoDyn’ new $87.5 million licensing deal for commercializing Leronlimab to treat HIV, as well as the […]

Healthcare

CytoDyn (OTC: CYDY) Announces FDA Clearance to Proceed with Phase 2 Study of Leronlimab (PRO 140) and Regorafenib as a Combination Therapy for Metastatic Colorectal Cancer

September 9, 2019 admin Healthcare, Newsmakers Comments Off on CytoDyn (OTC: CYDY) Announces FDA Clearance to Proceed with Phase 2 Study of Leronlimab (PRO 140) and Regorafenib as a Combination Therapy for Metastatic Colorectal Cancer

VANCOUVER, Washington, Sept. 09, 2019 — CytoDyn Inc. (otc.qb:CYDY), (“CytoDyn” or the “Company”), a late stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that […]

Investor Presentations

FSD Pharma (CSE: HUGE) (OTC: FSDDF) Investor Presentation by Dr. Raza Bokhari New Green Frontier Cannabis Investor Conference

November 21, 2018 admin Investor Presentations Comments Off on FSD Pharma (CSE: HUGE) (OTC: FSDDF) Investor Presentation by Dr. Raza Bokhari New Green Frontier Cannabis Investor Conference

      FSD Pharma (CSE: HUGE) (OTC: FSDDF) Investor Presentation by CEO Dr. Raza Bokhari at the New Green Frontier Cannabis Investor Conference Get our FREE Newsletter! Discover Stocks with +1,000% Upside Potential! Thank […]